Epidemiological features of type 2 diabetes;Épidémiologie du diabète de type 2

Revue du Praticien

Volumn 60, Issue 4, 2010, Pages

  Simon, Dominique ^a,b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; LIFE EXPECTANCY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; POPULATION RESEARCH; PREVALENCE; REVIEW; ARTICLE; RACE; RISK FACTOR;

CONTINENTAL POPULATION GROUPS; DIABETES MELLITUS, TYPE 2; HUMANS; PREVALENCE; RISK FACTORS;

EID: 77951997699     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. Report of a World Health Organization/International Diabetes Federation Consultation. Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia. WHO Document production service, Geneva, 2006.
2. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010;33.S62-9.
3. DECODE Study Group, European Diabetes Epidemiology Group. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour glucose diagnostic criteria. Arch Int Med 2001;161:397-405.
4. International Expert Committee. International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes. Diabetes Care 2009;32.1327-34.
5. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27.1047-53.
6. Chan JCN, Malik V, Jia W, et al. Diabetes in Asia. Epidemiology, risk factors, and pathophysiology. JAMA 2009;301:2129-2140.
7. Ricordeau P, Weill A, Vallier N, Bourrel R, Fender P, Allemand H. L'épidémiologie du diabète en France métropolitaine. Diabetes Metab 2000;26:S11-24.
8. Cogneau J, Balkau B, Weill A, Liard F, Simon D. Assessment of diabetes screening by general practitioners in France: the EPIDIA Study. Diabetic Med 2006,23:803-807 (Pubitemid 44366081)
9. Kusnik-Joinville O, Weill A, Salanave B, Ricordeau P, Allemand H. Diabetes prevalence and treatment of diabetic patients in France: trends between 2000 and 2005. Diabetes Metab 2008,34:266-272.
10. Kusnik-Joinville O, Weill A, Ricordeau P, Allemand H. Diabète traité en France en 2007: un taux de prévalence proche de 4% et des disparités géographiques croissantes. BEH 2008;43.409-13.
11. Schulz LO, Bennett PH, Ravussin E, et al. Effects of traditional and western environments on prevalence of type 2 diabetes in Pima Indians in Mexico and the US. Diabetes Care 2006;29:1866-1871 (Pubitemid 44156644)
12. Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and diabetes study. Diabetes Care 1997;20:537-544.
13. Tuomilehto J, Lindström J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-1350 (Pubitemid 32378388)
14. Knowter WC, Barrett-Connor E, Fowler SE, et al. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403.
15. Vague J. The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout and calculous disease. Am J Clin Nutr 1956;4:20-34.
16. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988;37:1595-1607.
17. Charles MA, Eschwege E, Basdevant A. Monitoring the obesity epidemic in France. the OBEPI surveys 1997-2006. Obesity 2008;16:2182-2186.